课题基金 / 基金详情

ACTG 5178

ACTG 5178
ACTG 5178
批准号:
7604606
负责人:
Mark Sebastian Sulkowski
金额:
$8.35万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-12-01 至 2007-09-16

项目摘要

项目成果

Mark Sebastian Sulkowski的其他基金

相关文献

中文摘要
翻译
这个子项目是众多研究子项目之一
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This is a phase II, open-label, two-arm, long-term maintenance therapy study. This trial is designed to study whether long-term maintenance with pegylated-interferon alfa-2a (PEG-IFN) reduces the rate of liver fibrosis progression in subjects with HCV/HIV co-infection who have failed to achieve or maintain HCV loads below the limit of detection during treatment with PEG-IFN plus ribavirin. Both HCV treatment na¿ve and previously treated subjects will be enrolled.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Patient Oriented Research in Hepatitis C-infected Injection Drug Users
  • 批准号:
    8457025
  • 项目类别:
  • 资助金额:
    $11.86万
  • 财政年份:
    2012
  • 负责人:
    Mark Sebastian Sulkowski
  • 依托单位:
Patient Oriented Research in Hepatitis C-infected Injection Drug Users
  • 批准号:
    8640131
  • 项目类别:
  • 资助金额:
    $11.86万
  • 财政年份:
    2012
  • 负责人:
    Mark Sebastian Sulkowski
  • 依托单位:
Patient Oriented Research in Hepatitis C-infected Injection Drug Users
  • 批准号:
    9039024
  • 项目类别:
  • 资助金额:
    $11.86万
  • 财政年份:
    2012
  • 负责人:
    Mark Sebastian Sulkowski
  • 依托单位:
Midcareer Investigator Award in Patient-Oriented Research (Parent K24)
  • 批准号:
    9561374
  • 项目类别:
  • 资助金额:
    $12.2万
  • 财政年份:
    2012
  • 负责人:
    Mark Sebastian Sulkowski
  • 依托单位: